Akso Health Group Sponsored ADR AHG
0.75
(0.01)
(1.32%)
as of 25 Sep
- Market cap
- $649.1M
- P/E
- 0.0×
Follow AHG
| Sep '25 | Sep '24 | Sep '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | (99.22%) | (139.96%) |
+8 more TTM periods Free account |
|
| 0.00% | 0.00% | (49.98%) | (69.78%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | (231.55%) | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 105.61 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | (0.54) | (0.52) | |
Free Cash Flow |
(182.54) | (9.50) | (12.44) | (11.88) | |
Capital Expenditures |
(177.19) | (1.59) | — | — | |
Piotroski F-Score |
— | — | 2.00 | — | |
| Other line items | |||||
Cash ROIC |
(2.55%) | (2.67%) | (83.50%) | (71.34%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 1.57 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
— | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | |
Operating CF/Net income |
0.00 | 0.00 | 1.01 | 0.65 | |
Depreciation/Fixed assets |
107.92 | 5.41 | — | — | |
Capex/Depreciation |
(106.62) | (2.59) | — | — | |
Revenue per Share |
— | — | 0.88 | 0.85 | |
Operating CF per Share |
0.00 | 0.00 | (0.54) | (0.52) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
— | — | (61.29%) | (93.34%) |
Columns are period end dates